• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Limb salvage for skeletal and soft tissue sarcomas. Multidisciplinary preoperative therapy.

作者信息

Eilber F R, Morton D L, Eckardt J, Grant T, Weisenburger T

出版信息

Cancer. 1984 Jun 15;53(12):2579-84. doi: 10.1002/1097-0142(19840615)53:12<2579::aid-cncr2820531202>3.0.co;2-v.

DOI:10.1002/1097-0142(19840615)53:12<2579::aid-cncr2820531202>3.0.co;2-v
PMID:6372980
Abstract

One hundred eighty-three patients with malignant skeletal (83) or soft tissue sarcoma (100) were entered into the multimodality preoperative limb salvage protocol. Local recurrences were observed in 5 of 183 (2.7%). Six patients required amputation because of complications, and 13 patients died within 1 year from metastatic disease. There was no statistical difference in survival rates between a series of patients who had amputation and adjuvant therapy and patients treated by limb salvage and adjuvant therapy. Overall survival rates for patients with soft tissue sarcoma were 76%. Although the exact reason for the improved local control is not known, it is our belief that it is the result of the multidisciplinary therapy that destroys microscopic disease at the periphery of the primary tumor.

摘要

相似文献

1
Limb salvage for skeletal and soft tissue sarcomas. Multidisciplinary preoperative therapy.
Cancer. 1984 Jun 15;53(12):2579-84. doi: 10.1002/1097-0142(19840615)53:12<2579::aid-cncr2820531202>3.0.co;2-v.
2
Is amputation necessary for sarcomas? A seven-year experience with limb salvage.肉瘤是否需要截肢?保肢治疗七年经验。
Ann Surg. 1980;192(4):431-8. doi: 10.1097/00000658-198010000-00001.
3
Limb salvage from a multidisciplinary treatment approach for skeletal and soft tissue sarcomas of the extremity.通过多学科治疗方法对肢体骨骼和软组织肉瘤进行保肢治疗。
Ann Surg. 1976 Sep;184(3):268-78. doi: 10.1097/00000658-197609000-00004.
4
Multidisiciplinary "limb salvage" treatment of soft tissue and skeletal sarcomas.软组织和骨肉瘤的多学科“保肢”治疗
Int J Radiat Oncol Biol Phys. 1981 Nov;7(11):1495-9. doi: 10.1016/0360-3016(81)90077-8.
5
Endoprosthetic reconstruction for large extremity soft-tissue sarcoma with juxta-articular bone involvement: functional and survival outcome.关节旁骨受累的大型肢体软组织肉瘤的人工假体重建:功能和生存结果。
J Surg Res. 2014 Mar;187(1):142-9. doi: 10.1016/j.jss.2013.09.004. Epub 2013 Sep 29.
6
Limb salvage therapy for soft tissue sarcomas of the foot.足部软组织肉瘤的保肢治疗
Int J Radiat Oncol Biol Phys. 1990 Jul;19(1):41-8. doi: 10.1016/0360-3016(90)90132-4.
7
Preoperative regional therapy for extremity sarcoma. A tricenter update.肢体肉瘤的术前区域治疗。三中心最新进展。
Cancer. 1995 May 1;75(9):2299-306. doi: 10.1002/1097-0142(19950501)75:9<2299::aid-cncr2820750919>3.0.co;2-y.
8
[Rotationplasty in the surgical treatment plan of primary malignant bone tumors. Possibilities and limits].[旋转成形术在原发性恶性骨肿瘤手术治疗方案中的应用。可能性与局限性]
Orthopade. 2003 Nov;32(11):965-70. doi: 10.1007/s00132-003-0550-y.
9
[Intra-arterial high-dose adriamycin in patients with malignant bone or soft tissue tumors. The factors in poor prognosis].[动脉内高剂量阿霉素治疗恶性骨或软组织肿瘤患者。预后不良的因素]
Gan To Kagaku Ryoho. 1988 Aug;15(8 Pt 2):2453-8.
10
Limb-sparing surgery for extremity sarcomas after preoperative intraarterial doxorubicin and radiation therapy.术前动脉内给予阿霉素和放疗后肢体肉瘤的保肢手术
Am J Surg. 1985 Jul;150(1):109-13. doi: 10.1016/0002-9610(85)90018-2.

引用本文的文献

1
The Landmark Series: Neoadjuvant Radiotherapy in Extremity Soft Tissue Sarcoma-The Way to Hypofractionation.里程碑系列:肢体软组织肉瘤的新辅助放疗——大分割放疗之路
Ann Surg Oncol. 2025 Mar;32(3):1489-1496. doi: 10.1245/s10434-024-16729-0. Epub 2025 Jan 3.
2
Development of nomogram and discussion of radiotherapy effect for osteosarcoma survival.列线图的建立与探讨对骨肉瘤生存的放疗效果。
Sci Rep. 2023 Jan 5;13(1):223. doi: 10.1038/s41598-023-27476-9.
3
Long-Term Follow-Up of Patients Receiving Neoadjuvant Treatment Modalties for Soft Tissue Sarcomas of the Extremities.
接受肢体软组织肉瘤新辅助治疗方式患者的长期随访
Cancers (Basel). 2021 Oct 19;13(20):5244. doi: 10.3390/cancers13205244.
4
Primary and radiation induced skull base osteosarcoma: a systematic review of clinical features and treatment outcomes.原发性和放射性诱导的颅底骨肉瘤:临床特征和治疗结果的系统评价。
J Neurooncol. 2021 Jun;153(2):183-202. doi: 10.1007/s11060-021-03757-z. Epub 2021 May 17.
5
Triggered radiosensitizer delivery using thermosensitive liposomes and hyperthermia improves efficacy of radiotherapy: An in vitro proof of concept study.采用热敏脂质体和热疗触发增敏剂递送提高放射治疗疗效的体外概念验证研究。
PLoS One. 2018 Sep 18;13(9):e0204063. doi: 10.1371/journal.pone.0204063. eCollection 2018.
6
Neoadjuvant sequential chemoradiotherapy versus radiotherapy alone for treatment of high-risk extremity soft tissue sarcoma: a single-institution experience.新辅助序贯放化疗与单纯放疗治疗高危肢体软组织肉瘤:单机构经验
Contemp Oncol (Pozn). 2017;21(1):60-65. doi: 10.5114/wo.2017.66658. Epub 2017 Mar 22.
7
Preoperative therapy for extremity soft tissue sarcomas.肢体软组织肉瘤的术前治疗。
Curr Treat Options Oncol. 2015 Jun;16(6):25. doi: 10.1007/s11864-015-0346-4.
8
A non-comparative phase II study of dose intensive chemotherapy with doxorubicin and ifosfamide followed by high dose ICE consolidation with PBSCT in non-resectable, high grade, adult type soft tissue sarcomas.一项非比较性的 II 期研究,旨在评估多柔比星和异环磷酰胺剂量强化化疗,随后进行高剂量 ICE 巩固治疗,并联合 PBSCT,用于不可切除的高级别成人型软组织肉瘤。
Invest New Drugs. 2013 Dec;31(6):1592-601. doi: 10.1007/s10637-013-0027-8. Epub 2013 Oct 4.
9
Quality of life following amputation or limb preservation in patients with lower extremity bone sarcoma.下肢骨肉瘤患者截肢或保肢治疗后的生活质量。
Front Oncol. 2013 Aug 14;3:210. doi: 10.3389/fonc.2013.00210. eCollection 2013.
10
Prognostic variables in patients with primary soft tissue sarcoma of the extremity and trunk treated with neoadjuvant radiotherapy or neoadjuvant sequential chemoradiotherapy.四肢和躯干原发性软组织肉瘤患者在新辅助放疗或新辅助序贯放化疗治疗中的预后变量。
Radiat Oncol. 2013 Mar 14;8:60. doi: 10.1186/1748-717X-8-60.